Endogenous neurotoxins relevant to schizophrenia

Journal of the Royal Society of Medicine

Volumn 89, Issue 12, 1996, Pages 679-680

  Smythies, John ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 CYSTEINYLDOPAMINE; ADRENOCHROME; DOPAMINE; MANDELIC ACID; NEUROMELANIN; NEUROTOXIN; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ADRENERGIC NERVE CELL; APOPTOSIS; DOPAMINOCHROME; HUMAN; METHYLATION; NORADRENOCHROME; SCHIZOPHRENIA; SHORT SURVEY;

EID: 0030459314     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107689608901206     Document Type: Short Survey

References (27)

1. Hoffer A, Osmond H, Smythies JR. Schizophrenia. A new approach. Part II. J Ment Sci 1954;100:29-45
2. Grof S. Clinical and experimental study of central effects of adrenochrome. J Neuropsychiat 1963;5:33-50
3. Schwarz BE, Sem-Jacobsen C, Petersen MC. Effects of mescaline, LSD-25 and adrenochrome on depth electrograms in man. Arch Neurol Psychiat 1956;75:579-87
4. Taubman G, Jantz H. Untersuchung über die dem adrenochrom zugeschrieben psychotoxischen wirkungen. Nervenartz 1957;28:485-8
5. Rinkel M, Solomon AC. Chemical theories of psychosis. J Clin Exp Psychopathol 1957;18:323-35
6. Taborsky RG. Indoxyl derivatives: potential psychotropic metabolites. Int J Neuropharmacol 1968;7:483-6
7. Graham DG. Oxidative pathways for catecholamines in the genesis of neuromelanin and psychotoxic quinones. Mol Pharmacol 1978;14: 633-43
8. Pileblad E, Slivka A, Bratvold D, Cohen G. Studies on the autooxidation of dopamine: interaction with ascorbate. Arch Biochem Biophys 1988;263:447-52
9. Shafritz D, Goodwin F, Weissbach H. Inhibition by aminochromes of in vitro synthesis in Escherichia coli. Arch Biochem Biophys 1969;134:478-85
10. Carstam R, Brinck C, Hindemith-Augustsson A, Rorsman H, Rosengren E. The neuromelanin of the human substantia nigra. Biochim Biophys Acta 1991;1097:152-60
11. Goodwill F, Shafritz D, Weissbach H. In vitro polypeptide synthesis in brain. Arch Biochem Biophys 1965;130:183-90
12. Hastings TG. Enzymatic oxidation of dopamine: the role of prostaglandin H synthetase. J Neurochem 1995;64:919-24
13. Mattammal MB, Strong R, Lakshuri VM, Chung HD, Stephenson AH. Prostaglandin H synthetase-mediated metabolism of dopamine: implication for Parkinson's disease. J Neurochem 1995;64:1645-54
14. Geiger R. Effects of LSD-25, serotonin and sera from schizophrenics on adult mammalian brain cultures. J Neuropsychiat 1960;1:185-99
15. Enochs WS, Sarna T, Zecca L, Riley PA, Swartz HM. The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis. J Neurotrans [P-D section] 1994;7:83-100
16. Garey LJ, Ong UY, Patel TS, et al. Reduction in dendritic spine number on cortical neurons in schizophrenia. Abst Soc Neurosci 1995;21:236
17. Glantz LA, Lewis DA. Assessment of spine density on layer III pyramidal cells in the prefrontal cortex of schizophrenic subjects. Abst Soc Neurosci 1995;21:237
18. Akil M, Lewis DA. The catecholaminergic innervation of the human entorhinal cortex: alteration in schizophrenia. Abstr Soc Neurosci 1995;21:238
19. Filloux F, Townsend JJ. Pre- and post-synaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol 1993;119:79-88
20. Avoca P, Solano F, Salinas C, García-Borrón JC, Lozano JA. Regulation of the final phase of mammalian melanogenesis. Eur J Biochem 1992;208:155-63
21. Smit NPM, Pavel S, Kammayer A, Westerhof W. Determination of catechol O-methyltransferase activity in relation to melanin metabolism using high-performance liquid chromatography with fluorimetric detection. Anal Biochem 1990;190:286-91; and see also Nicolaus RA. Melanins. Paris: Herman, 1968.
22. Smit NPM, Pavel S, Kammayer A, Westerhof W. Determination of catechol O-methyltransferase activity in relation to melanin metabolism using high-performance liquid chromatography with fluorimetric detection. Anal Biochem 1990;190:286-91; and see also Nicolaus RA. Melanins. Paris: Herman, 1968.
23. Kelsoe JR Jr, Tolbert LC, Crews EL, Smythies JR. Kinetic evidence for decreased methionine adenosyltransferase activity in erythrocytes from schizophrenics. J Neurosci Res 1982;8:99-103
24. Regland B, Johansson BV, Grenfeldt B, Hjelmgren LT, Medhus M. Homocysteinemia is a common feature of schizophrenia. J Neural Transm [Gen Sect] 1995;100:1391-8
25. Sargent T III, Kusubov N, Taylor SE, Budinger TF. Tracer kinetic evidence for abnormal methyl metabolism in schizophrenia. Biol Psychiatr 1992;32:1078-90
26. Carlsson A, Waters N, Hansson IO. Neurotransmitter aberrations in schizophrenia: new findings. In: Fog R, Gerlach J, Hemmingsen R, eds. Schizophrenia. An Integrated View. Proceedings of a svmposium held at the Royal Danish Academy of Sciences and Letters, 5-9 June 1994.
27. Smythies J. On the function of neuromelanin. Proc R Soc B 1996;263:987-989